Related Experiment Video

Updated: Feb 8, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

13.1K

Dynamic microRNA activity identifies therapeutic targets in trastuzumab-resistant HER2+ breast cancer

Joseph T Decker1, Matthew S Hall1, Rachel B Blaisdell1

  • 1Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan.

Biotechnology and Bioengineering
|July 8, 2018
PubMed

Insights

Researchers developed a novel system to monitor microRNA (miRNA) activity, revealing miR-21 downregulation as a key factor in trastuzumab resistance in HER2+ breast cancer models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play crucial roles in physiological and pathological processes, including chemotherapy resistance.
  • Current methods for assessing miRNA roles, such as PCR and microarrays, primarily measure abundance rather than dynamic activity.
  • Understanding dynamic miRNA activity is essential for identifying therapeutic targets in complex diseases like cancer.

Purpose of the Study:

  • To develop and apply a system for large-scale monitoring of dynamic miRNA activity.
  • To investigate the contribution of miRNA activity to trastuzumab resistance in HER2-positive breast cancer.
  • To identify specific miRNAs involved in the development of resistance to HER2-targeted therapy.

Main Methods:

  • Development of a lentiviral-based system with 32 miRNA reporter constructs for dynamic miRNA activity monitoring.
  • Quantification of miRNA activity using bioluminescence imaging in BT474 and trastuzumab-resistant BT474R HER2+ breast cancer cell lines.
  • Application of statistical, network, and classification analyses to dynamic miRNA activity data.

Main Results:

  • Significant differences in miRNA activity were observed between trastuzumab-sensitive and resistant HER2+ breast cancer cells.
  • Treatment with trastuzumab altered the activity of multiple miRNAs in both parental and resistant cell lines.
  • miR-21 was identified as a critical factor, with its downregulation associated with trastuzumab resistance, confirmed in SKBR3 cells.

Conclusions:

  • The developed system enables large-scale monitoring of dynamic miRNA activity, offering insights beyond static abundance measurements.
  • Dynamic miRNA profiling can identify key regulatory miRNAs, such as miR-21, involved in therapeutic resistance.
  • This approach provides a powerful tool for discovering novel therapeutic targets in treatment-resistant cancers.
Keywords:
breast cancerdrug resistancemicroRNAtrastuzumab

More Related Videos

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

8.0K
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.7K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Dynamic Equilibrium02:20

Dynamic Equilibrium

A reversible chemical reaction represents a chemical process that proceeds in both forward (left to right) and reverse (right to left) directions. When the rates of the forward and reverse reactions are equal, the concentrations of the reactant and product species remain constant over time and the system is at equilibrium. A special double arrow is used to emphasize the reversible nature of the reaction. The relative concentrations of reactants and products in equilibrium systems vary greatly;...
63.0K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K